Effect of intracoronary estradiol on postischemic microvascular damage in a porcine model: A myocardial contrast echocardiographic study

Angiology

Volumn 54, Issue 6, 2003, Pages 701-709

  Nishino, Masami ^a   Youn, Ho Joong ^a   Gheorghevici, Dorina ^a   Zellner, Christian ^a   Chou, Tony M ^a   Sudhir, Krishnankutty ^a   Redberg, Rita F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; ESTRADIOL; SHU 508;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BALLOON CATHETER; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; HEART MUSCLE INJURY; IMAGING; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MEASUREMENT; MICROANGIOPATHY; NONHUMAN; REPERFUSION; SWINE; VIDEODENSITOMETRY;

ANIMALS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; ESTRADIOL; MALE; MYOCARDIAL ISCHEMIA; RANDOM ALLOCATION; SWINE;

EID: 0344011570     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970305400610     Document Type: Article

References (35)

1. Kloner RA, Ganote CE, Jermings RB: The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54:1496-1508, 1974.
2. Ito H, Tomooka T, Sakai N, et al: Lack of myocardial perfusion immediately after successful thrombolysis: A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 85:1699-1705, 1992.
3. Feld H, Lichstein E, Schachter J, et al: Early and late angiographic findings of the "no-reflow" phenomenon following direct angioplasty as primary treatment for acute myocardial infarction. Am Heart J 123:782-785, 1992.
4. Pomerantz RM, Kuntz RE, Diver DJ, et al: Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following PTCA. Cathet Cardiovasc Diagn 24:283-285, 1991.
5. Ito H, Maruyama A, Iwakura K, et al: Clinical implication of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 93:223-228, 1996.
6. Sakuma T, Hayashi Y, Sumii K, et al: Prediction of short- and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization. J Am Coll Cardiol 32:890-897, 1998.
7. Piana RN, Paik GY, Moscucci M, et al: Incidence and treatment of "no-reflow" after percutaneous coronary intervention. Circulation 89:2514-2518, 1994.
8. Taniyama Y, Ito H, Iwakura K, et al: Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 30:1193-1199, 1997.
9. Higginson L, Tang A, Knoll G, et al: Effect of intracoronary diltiazem on infarct size and regional myocardial function in the ischemic reperfused canine heart. J Am Coll Cardiol 18:868-875, 1991.
10. Williams JK, Adams MR, Klopfenstein HS: Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81:1680-1687, 1990.
11. Sudhir K, Chou TM, Mullen WL, et al: Mechanisms of estrogen-induced vasodilation: In vivo studies in canine coronary conductance and resistance arteries. J Am Coll Cardiol 26:807-814, 1995.
12. Jiang C, Sarrel PM, Lindsay DC, et al: Endothelium-independent relaxation of rabbit coronary artery to 17β-oestradiol in vitro. Br J Pharmacol 104:1033-1037, 1991.
13. Jiang C, Sarrel PM, Poole-Wilson PA, et al: Acute effect of 17β-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol 263:H271-H275, 1992.
14. Collins P, Rosano GM, Jiang C, et al: Cardiovascular protection by oestrogen - a calcium antagonist effect? Lancet 341:1264-1265, 1993.
15. Asanuma T, Tanabe K, Ochiai K, et al: Relationship between progressive microvascular damage and intramyocardial hemorrhage in patients with reperfused anterior myocardial infarction: Myocardial contrast echocardiographic study. Circulation 96:448-453, 1997.
16. Porter TR, Xie F, Kricsteld D, et al: Improved myocardial contrast with second harmonic transient ultrasound response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albumin. J Am Coll Cardiol 27:1497-1501, 1996.
17. 31P-MRS study. Circulation 94:1089-1100, 1996.
18. Kaul S: Myocardial contrast echocardiography. 15 years of research and development. Circulation 96:3745-3760, 1997.
19. Burns PN: Ultrasound contrast agents in radiological diagnosis. Radiol Med Torino 87(suppl 1):71-82, 1994.
20. Ito H, Iwakura K, Oh H, et al: Temporal changes in myocardial perfusion patterns in patients with reperfused anterior wall myocardial infarction. Their relation to myocardial viability. Circulation 91:656-662, 1995.
21. Schiller NB, Shah PM, Crawford M, et al: Recommendations of quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2:358-367, 1989.
22. Sawada SG, Segar DS, Ryan T, et al: Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 83:1605-1614, 1991.
23. Kloner RA, Prynzklenk K: Experimental infarct size reduction with calcium channel blockers. J Am Coll Cardiol 18:876-878, 1991.
24. Campbell CA, Kloner RA, Alker K, et al: Effect of verapamil on infarct size in dogs subjected to coronary artery occlusion with transient reperfusion. J Am Coll Cardiol 8:1169-1174, 1986.
25. Braun S, Bokyo V, Behar S, et al: Calcium antagonists and mortality in patients with coronary artery disease: A cohort study of 11,575 patients. J Am Coll Cardiol 28:7-11, 1996.
26. Michels KB, Rosner BA, Manson JE, et al: Prospective study of calcium channel blocker use, cardiovascular disease, and total mortality among hypertensive women: The Nurses' Health Study. Circulation 98:1529-1531, 1998.
27. Leitch JW, McElduff P, Dobson A, et al: Outcome with calcium channel antagonists after myocardial infarction: A community-based study. J Am Coll Cardiol 31:118-119, 1998.
28. Delyani JA, Murohara T, Nossuli TO, et al: Protection from myocardial reperfusion injury by acute administration of 17β-estradiol. J Mol Cell Cardiol 28:1001-1008, 1996.
29. Sudhir K, Ko E, Chou TM, et al: Physiological concentrations of estradiol attenuate endothelin 1-induced coronary vasoconstriction in vivo. Circulation 96:3626-3632, 1997.
30. Node K, Kitakaze M, Kosaka H, et al: Amelioration of ischemia- and reperfused-induced myocardial injury by 17β-estradiol. Role of nitric oxide and calcium-activated potassium channels. Circulation 96:1953-1963, 1997.
31. Deodato B, Altavilla D, Squadrito G, et al: Cardio-protection by the phytoestrogen genistein in extent of coronary microcirculation with myocardial contrast experimental myocardial ischaemia-reperfusion injury. Br J Pharmacol 128:1683-1690, 1999.
32. Ito H, Iwakura K: Assessing the relation between coronary reflow and myocardial reflow. Am J Cardiol 81:8G-12G, 1998.
33. Kaul S: Assessmyocardiography: Current and future clinical applications Br Heart J 73:490-495, 1995.
34. Kaul S, Pandian NG, Gillam LD, et al: Contrast echocardiography in acute myocardial ischemia: III. An in vivo comparison of the extent of abnormal wall motion with the area at risk for necrosis. J Am Coll Cardiol 7:383-392, 1986.
35. Sakamaki T, Corday E, Meerbaum S, et al: Relation between myocardial injury and postextrasystolic potentiation of regional function measured by two-dimensional echocardiography. J Am Coll Cardiol 2:52-62, 1983.